Back

The ApoB/LDL-C ratio predicts cardiovascular events in coronary artery disease patients independent of type 2 diabetes status

1 September 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Lp(a) and apoproteins as risk factors Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)

7 More presentations in this session

Presentation thumbnail
Lp(a) testing and LDL-C levels among australian ASCVD patients in 2022: a cross-sectional study from the advara heartcare network (PREVAIL)
Doctor R. SANTANI (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Does the LPA genotype have a role in coronary artery disease risk beyond Lp(a) values?
Doctor D. Sa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Comparison of Lp(a) assessment in patients with atherosclerotic cardiovascular disease between office-based cardiologists and general practitioners
Professor O. Weingaertner (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Causal associations of insulin and Lp(a) levels: a Mendelian randomization study
Associate Professor T. Osadnik (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
A retrospective analysis of patients with very HIGH level of LDL-C and the predictors of mortality (HIGH-LDL-PM Registry)
Associate Professor U. Sinan (Istanbul, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Lp(a) and apoproteins as risk factors

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
The LDL-C/Apo B ratio predicts mortality in heart failure patients both with and without type 2 diabetes
31 August 2025
thumbnail
Congress Presentation
The visceral adiposity index predicts the development of type 2 diabetes mellitus in patients with established coronary artery disease
31 August 2025
thumbnail
Congress Presentation
Specificities of dyslipidemia management in diabetic patients.
28 August 2022
thumbnail
Congress Presentation
Lipoprotein(a) and cardiovascular prognosis of familial dyslipidemias: data from a 10-year follow-up study
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources